CHBP induces stronger immunosuppressive CD127(+) M-MDSC via erythropoietin receptor.
CHBP induces stronger immunosuppressive CD127(+) M-MDSC via erythropoietin receptor.
复制标题
CHBP 通过促红细胞生成素受体诱导更强的免疫抑制 CD127( ) M-MDSC
DOI:
10.1038/s41419-021-03448-7
复制
发表时间:
2021-02-12
影响因子:
9
通讯作者:
Rong R
中科院分区:
文献类型:
--
作者:
Li J;Tu G;Zhang W;Zhang Y;Zhang X;Qiu Y;Wang J;Sun T;Zhu T;Yang C;Rong R
Erythropoietin (EPO) is not only an erythropoiesis hormone but also an immune-regulatory cytokine. The receptors of EPO (EPOR)2 and tissue-protective receptor (TPR), mediate EPO’s immune regulation. Our group firstly reported a non-erythropoietic peptide derivant of EPO, cyclic helix B peptide (CHBP), which could inhibit macrophages inflammation and dendritic cells (DCs) maturation. As a kind of innate immune regulatory cell, myeloid-derived suppressor cells (MDSCs) share a common myeloid progenitor with macrophages and DCs. In this study, we investigated the effects on MDSCs differentiation and immunosuppressive function via CHBP induction. CHBP promoted MDSCs differentiate toward M-MDSCs with enhanced immunosuppressive capability. Infusion of CHBP-induced M-MDSCs significantly prolonged murine skin allograft survival compared to its counterpart without CHBP stimulation. In addition, we found CHBP increased the proportion of CD11b+Ly6G−Ly6Chigh CD127+ M-MDSCs, which exerted a stronger immunosuppressive function compared to CD11b+Ly6G−Ly6Chigh CD127− M-MDSCs. In CHBP induced M-MDSCs, we found that EPOR downstream signal proteins Jak2 and STAT3 were upregulated, which had a strong relationship with MDSC function. In addition, CHBP upregulated GATA-binding protein 3 (GATA-3) protein translation level, which was an upstream signal of CD127 and regulator of STAT3. These effects of CHBP could be reversed if Epor was deficient. Our novel findings identified a new subset of M-MDSCs with better immunosuppressive capability, which was induced by the EPOR-mediated Jak2/GATA3/STAT3 pathway. These results are beneficial for CHBP clinical translation and MDSC cell therapy in the future.
登录
查看更多内容
影响因子:
9
作者:
Yang C;Zhang Y;Wang J;Li L;Wang L;Hu M;Xu M;Long Y;Rong R;Zhu T
通讯作者:
Zhu T
影响因子:
64.5
作者:
Zheng, WP;Flavell, RA
通讯作者:
Flavell, RA
影响因子:
6.4
作者:
Wegner, Anja;Verhagen, Johan;Wraith, David C.
通讯作者:
Wraith, David C.
影响因子:
8
作者:
Shan, L.;Li, X.;Shi, L.
通讯作者:
Shi, L.
影响因子:
7.4
作者:
Wang S;Zhang C;Niyazi S;Zheng L;Li J;Zhang W;Xu M;Rong R;Yang C;Zhu T
通讯作者:
Zhu T